Thirteen years ago, Congress promised wholesale drug distributors a simpler life. The Drug Supply Chain Security Act passed in 2013. It told the FDA to write one national standard for licensing wholesalers and 3PLs. A distributor serving forty states would no longer need forty separate permission slips to exist.
The FDA published its proposed rule in February 2022. Comments closed that September. And then, quiet. The final rule still has not arrived. Every wholesaler in the country is living in the world the law was supposed to retire.
What the patchwork actually costs you
Until a final rule lands, licensing stays state by state, and the states do not agree on much. Renewal cycles differ. So do fees, bond amounts, rules about designated reps, and whether your home-state inspection counts for anything. A distributor licensed in thirty states is not running one compliance program. It is running thirty, and the calendar never stops.
That is the pain the national standard is supposed to fix, eventually. When it arrives, it should genuinely help: one set of standards, one vocabulary, fewer duplicate hoops. If you hold licenses in a stack of states, the final rule is worth watching for.
The license the FDA wants to simplify is yours. The fifty boards that matter most are your customers’.
The compliance job no federal rule touches
Here is the part that gets missed. A wholesaler’s compliance life has two ledgers. The first is your own licensing, the stack of state permits the FDA rule would streamline. The second is checking the people you sell to, and no national license touches that one.
Every pharmacy you ship to holds its license from a state board. Those boards suspend, revoke, and discipline all year long, on their own schedules, in their own databases. The DEA registration some of your customers carry is separate again. So is the NPI registry. When a customer’s license lapses on a Tuesday, nobody calls you. The order they place on Wednesday looks exactly like last month’s.
That second ledger is where the real exposure lives. Selling to a suspended pharmacy is the mistake regulators do not forgive. It stays a fifty-board problem no matter what happens to the FDA’s rule, and it grows with your customer list.
The calendar is not waiting either
While the licensing rule sits in review, the rest of DSCSA keeps arriving on schedule. Package-level electronic tracing has been the law since late 2024. The last exemption standing, for small dispensers, ends on November 27, 2026. After that, the smallest pharmacies you serve are inside the same tracing rules as everyone else.
More tracing means more visibility, and more visibility cuts both ways. The same records that prove where product went also show exactly who it went to. A gap nobody could see in a paper world is easy to see in a traced one.
The play to run this week
Pull your top twenty accounts. For each one, ask when its license was last checked against the state board, not against your onboarding file. For most operations the honest answer is “when we set them up,” which might be years and several board actions ago. Then check who on your list holds a DEA registration, and when that was last confirmed.
If the pull takes more than a few minutes, or the answers all point to onboarding day, that is the finding. Your own licenses have a renewal calendar screaming at you. Your customers’ licenses have nobody, unless you have built the watching yourself.
Worth ten minutes: WorkdID checks every customer license against all fifty state boards, the NPI registry, and the DEA list, every day, and validates them at order time. If the pull above took longer than it should have, get a free check of your top accounts. No system access needed, results in a business day.
Sources
- FDA Announces Proposed Rule: National Standards for Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers · U.S. Food & Drug Administration
- National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers · Federal Register, 4 February 2022
- Drug Supply Chain Security Act (DSCSA) · U.S. Food & Drug Administration